Cannae (NYSE:CNNE - Get Free Report) posted its earnings results on Monday. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03), Zacks reports. The company had revenue of $109.90 million during the quarter, compared to the consensus estimate of $105.90 million. Cannae had a negative return on equity of 8.26% and a negative net margin of 68.61%.
Cannae Stock Up 1.8 %
NYSE:CNNE traded up $0.36 during midday trading on Thursday, reaching $19.88. 306,903 shares of the stock traded hands, compared to its average volume of 328,444. The stock has a market capitalization of $1.25 billion, a PE ratio of -4.14 and a beta of 0.87. Cannae has a 12-month low of $16.94 and a 12-month high of $22.99. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.55 and a current ratio of 2.55. The business has a 50-day moving average of $19.51 and a two-hundred day moving average of $19.68.
Cannae Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.42%. The ex-dividend date of this dividend is Monday, March 17th. Cannae's dividend payout ratio is currently -9.98%.
Analyst Ratings Changes
Separately, Royal Bank of Canada decreased their price target on Cannae from $27.00 to $23.00 and set an "outperform" rating on the stock in a report on Wednesday.
Check Out Our Latest Stock Report on Cannae
Cannae Company Profile
(
Get Free Report)
Cannae Holdings, Inc is a principal investment firm. The firm primarily invests in restaurants, technology enabled healthcare services, financial services and more. It takes both minority and majority stakes. Cannae Holdings, Inc was founded in 2014 and is based in Las Vegas, Nevada.
Further Reading

Before you consider Cannae, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cannae wasn't on the list.
While Cannae currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.